B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer

被引:87
作者
Liu, Yu [1 ]
Zeng, Bin [1 ]
Zhang, Zhuohan [1 ]
Zhang, Yuan [1 ]
Yang, Rongcun [1 ]
机构
[1] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China
关键词
Myeloid-derived suppressor cells; B7-H1; Immune suppression;
D O I
10.1016/j.clim.2008.07.030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) accumulate in tumor-bearing hosts and are associated with immune suppression. Here, we described high level of expression of B7-H1 (CD274), PD-1 (CD279) and CTLA4 (CD152) by Gr-1(+)CD11b(+) MDSCs obtained from both ascites and spleens of mice bearing the 1D8 ovarian carcinoma, whereas B7-DC (CD273), CD40 and CD86 were absent. In contrast, B7-H1, PD-1 and CTLA-4 expression was not detected on Gr-1(+)CD11b(+) cells from naive mice. Expression of B7-H1 by Gr-1(+)CD11b(+) cells from naive mice could be induced by co-culture with 1D8 ovarian carcinoma cells. Gr-1(+)CD11b(+) cells derived from 1D8 tumor-bearing mice markedly suppressed antigen-specific immune responses, whereas Gr-1(+)CD11b(+) cells from naive mice did not. siRNA-mediated knockdown of B7-H1 in Gr-1(+)CD11b(+) cells of 1D8 tumor-bearing mice alleviated suppression of antigen-specific immune responses. Suppression of antigen-specific immune responses via B7-H1 on Gr-1(+)CD11b(+) myeloid cells was mediated by CD4(+)CD25(+) Foxp3(+) T regulatory cells and required PD-1. Antibody blockade of either B7-H1 or PD-1 retarded the growth of 1D8 tumor in mice. This suggests that expression of B7-H1 on Gr-1(+)CD11b(+) myeloid cells triggered by the 1D8 mouse model of ovarian carcinoma suppresses antigen-specific immunity via interaction with PD-1 on CD4(+)CD25(+) Foxp3(+) regulatory T cells. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 49 条
[1]   Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[2]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[3]   Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes [J].
Apolloni, E ;
Bronte, V ;
Mazzoni, A ;
Serafini, P ;
Cabrelle, A ;
Segal, DM ;
Young, HA ;
Zanovello, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :6723-6730
[4]   Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[5]   Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro [J].
Blank, C ;
Kuball, J ;
Voelkl, S ;
Wiendl, H ;
Becker, B ;
Walter, B ;
Majdic, O ;
Gajewski, TF ;
Theobald, M ;
Andreesen, R ;
Mackensen, A .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (02) :317-327
[6]   Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism [J].
Blazar, BR ;
Carreno, BM ;
Panoskaltsis-Mortari, A ;
Carter, L ;
Iwai, Y ;
Yagita, H ;
Nishimura, H ;
Taylor, PA .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1272-1277
[7]  
Bronte V, 1999, J IMMUNOL, V162, P5728
[8]  
Bronte V, 1998, J IMMUNOL, V161, P5313
[9]   Tumor-induced immune dysfunctions caused by myeloid suppressor cells [J].
Bronte, V ;
Serafini, P ;
Apolloni, E ;
Zanovello, P .
JOURNAL OF IMMUNOTHERAPY, 2001, 24 (06) :431-446
[10]   Current concepts of tumor-infiltrating lymphocytes in human malignancies [J].
Chiou, SH ;
Sheu, BC ;
Chang, WC ;
Huang, SC ;
Ho, HN .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2005, 67 (1-2) :35-50